Bassett Furniture Industries is a retailer, manufacturer and marketer of branded home furnishings. The company's products are sold primarily through a network of the company-owned and licensee-owned branded stores under the Bassett Home Furnishings (BHF) name. The company's wholesale home furnishings segment is involved principally in the design, manufacture, sourcing, sale and distribution of furniture products to a network of BHF stores and independent furniture retailers. The company's Retail segment includes its store network of the company-owned stores and licensee-owned stores. The company's Logistical Services segment provides network line haul freight (middle mile) and warehousing, distribution and inventory management.

Concrete Pumping Holdings is a holding company. Through its subsidiaries, the company is engaged in the concrete pumping services and concrete waste management services in the United States and the United Kingdom. The company operates through the following three reportable segments: United States Concrete Pumping, which provides concrete pumping services under its Brundage-Bone and Capital Pumping brands; United States Concrete Waste Management Services, which provides concrete waste management services through its Eco-Pan, Inc. business; United Kingdom Operations, which provides concrete pumping services through its Camfaud brand or its Premier Concrete Pumping brand.

KeyCorp is a bank holding company. Through its principal subsidiary, KeyBank National Association and certain other subsidiaries, the company has the following main business segments: Consumer Bank, which serves individuals and small businesses by providing a variety of deposit and investment products, personal finance and financial wellness services, lending, mortgage and home equity, student loan refinancing, credit card, treasury services, and business advisory services; and Commercial Bank, which is focused principally on serving the needs of middle market clients in the following industry sectors, including consumer, energy, healthcare, industrial, public sector, real estate, and technology.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

TransDigm Group is a holding company. Through its subsidiaries, the company designs, produces and supplies aircraft components for use on commercial and military aircraft. The company's segments are: Power and Control, which develops, produces and markets systems and components that provide power to or control power of the aircraft utilizing electronic, fluid, power and mechanical motion control technologies; Airframe, which develops, produces and markets systems and components that are used in non-power airframe applications utilizing airframe and cabin structure technologies; and Non-aviation, which develops, produces and markets products for non-aviation markets.

Trecora Resources is engaged in the manufacturing of various petrochemical products and synthetic waxes and the provision of custom processing services. The company also owns an interest in Al Masane Al Kobra Mining Company, a Saudi Arabian closed joint stock mining company, which is engaged in the commercial production of copper and zinc concentrates and silver and gold dore, and an interest in Pioche Ely Valley Mines, Inc., a mining corporation which owns undeveloped properties in the U.S. The company has two segment: the manufacturing of various specialty petrochemical products through South Hampton Resources, Inc. and the manufacturing of specialty synthetic waxes through Trecora Chemical, Inc.

XOMA is a biotech royalty aggregator with a portfolio of pre-commercial therapeutic candidates. The company's monoclonal antibodies and technologies product candidates are: IL-2, which targets Interleukin 2 as a therapy for metastatic melanoma and renal cell carcinoma; PTH1R, an anti-parathyroid receptor pipeline that includes several functional antibody antagonists targeting PTH1R, a G-protein-coupled receptor involved in the regulation of calcium metabolism; XMetA, an insulin receptor-activating antibody designed to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; X213, an allosteric inhibitor of prolactin action.